News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

Drug maker loses India patent battle

Started by riky, April 01, 2013, 09:00:22 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

Drug maker loses India patent battle

<p><a href="http://news.yahoo.com/drug-maker-loses-india-patent-battle-053713850--finance.html"><img src="http://l2.yimg.com/bt/api/res/1.2/TMQfk1ERf1UfXYxuFpRmNg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3B4b2ZmPTUwO3B5b2ZmPTA7cT04NTt3PTEzMA--/http://media.zenfs.com/en_us/News/ap_webfeeds/3651526ffd10c50a2d0f6a70670095e4.jpg" width="130" height="86" alt="FILE - In this Monday, Jan. 29, 2007 file photo, Indian police officers block demonstrators protesting against drug manufacturer Novartis' case against Indian government on drug patents in New Delhi, India. A lawyer for healthcare activists says India's Supreme Court has rejected drug maker Novartis AG' right to patent a new version of a lifesaving cancer drug. The landmark ruling Monday, April 1, 2013 is a victory for India's $26 billion generic drug industry that provides cheap medicines to millions around the world. Novartis has fought a legal battle in India since 2006 for a fresh patent for its cancer drug Glivec. (AP Photo/Saurabh Das, File)" align="left" title="FILE - In this Monday, Jan. 29, 2007 file photo, Indian police officers block demonstrators protesting against drug manufacturer Novartis' case against Indian government on drug patents in New Delhi, India. A lawyer for healthcare activists says India's Supreme Court has rejected drug maker Novartis AG' right to patent a new version of a lifesaving cancer drug. The landmark ruling Monday, April 1, 2013 is a victory for India's $26 billion generic drug industry that provides cheap medicines to millions around the world. Novartis has fought a legal battle in India since 2006 for a fresh patent for its cancer drug Glivec. (AP Photo/Saurabh Das, File)" border="0" /></a>NEW DELHI (AP) â€" India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent a new version of a cancer drug in a landmark decision that healthcare activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login